Dr. Jun Zhang
Claim this profileHouston Methodist Hospital
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
28 reported clinical trials
43 drugs studied
About Jun Zhang
Education:
- Received MD from Hunan Medical University, China.
Experience:
- Completed Internal Medicine Residency at New Hanover Medical Center, Wilmington, NC.
- Undertook Hematology-Oncology Fellowship at Brody School of Medicine, East Carolina University.
- Holds a faculty position at Baylor College of Medicine.
- Program Director of the Hematology-Oncology Fellowship at Houston Methodist Hospital since 2018.
- Focuses on thoracic oncology and head & neck cancer clinical research.
Area of expertise
1Non-Small Cell Lung Cancer
Stage IV
PD-L1 positive
Stage III
2Lung Cancer
Stage IV
Stage II
Stage III
Affiliated Hospitals
Clinical Trials Jun Zhang is currently running
Adagrasib Combo Therapy
for Lung Cancer
Study CA239-0010 is an open-label, Phase 2 clinical trial evaluating the clinical efficacy of adagrasib in combination with pembrolizumab and chemotherapy in the first-line setting for patients with advanced NSCLC with TPS ≥ 1%, TPS \<50% and KRAS G12C mutation
Recruiting1 award Phase 24 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
More about Jun Zhang
Clinical Trial Related3 years of experience running clinical trials · Led 28 trials as a Principal Investigator · 16 Active Clinical TrialsTreatments Jun Zhang has experience with
- Pembrolizumab
- Cisplatin
- Carboplatin
- Berzosertib
- Gemcitabine Hydrochloride
- Paclitaxel
Breakdown of trials Jun Zhang has run
Non-Small Cell Lung Cancer
Lung Cancer
Skin Cancer
Gastric Cancer
- Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative Gastric/Gastroesophageal Junction Adenocarcinoma
- A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression
- AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jun Zhang specialize in?
Jun Zhang focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are PD-L1 positive.
Is Jun Zhang currently recruiting for clinical trials?
Yes, Jun Zhang is currently recruiting for 10 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Jun Zhang has studied deeply?
Yes, Jun Zhang has studied treatments such as Pembrolizumab, Cisplatin, Carboplatin.
What is the best way to schedule an appointment with Jun Zhang?
Apply for one of the trials that Jun Zhang is conducting.
What is the office address of Jun Zhang?
The office of Jun Zhang is located at: Houston Methodist Hospital, Houston, Texas 77030 United States. This is the address for their practice at the Houston Methodist Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.